Literature DB >> 12508268

Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment.

Douglas E Sutherland1, Ilene C Weitz, Howard A Liebman.   

Abstract

The association between malignancy and clinical thrombosis has been recognized for nearly 140 years. The purpose of this review is to examine our current understanding of thrombosis as a complication of cancer and cancer therapy. The review includes a discussion of the epidemiology, pathophysiology, diagnosis and treatment. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12508268     DOI： 10.1002/ajh.10263

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


  43 in total

Review 1.  Thrombosis and cancer.

Authors:  Annie Young; Oliver Chapman; Carole Connor; Christopher Poole; Peter Rose; Ajay K Kakkar
Journal:  Nat Rev Clin Oncol       Date:  2012-07-10       Impact factor: 66.675

Review 2.  [Stroke in cancer patients. A paraneoplastic neurological syndrome?].

Authors:  W Grisold; M Födinger; S Oberndorfer
Journal:  Nervenarzt       Date:  2010-04       Impact factor: 1.214

Review 3.  Trousseau's syndrome: multiple definitions and multiple mechanisms.

Authors:  Ajit Varki
Journal:  Blood       Date:  2007-05-11       Impact factor: 22.113

Review 4.  Ischemic Heart Disease: Special Considerations in Cardio-Oncology.

Authors:  Dana Elena Giza; Fernando Boccalandro; Juan Lopez-Mattei; Gloria Iliescu; Kaveh Karimzad; Peter Kim; Cezar Iliescu
Journal:  Curr Treat Options Cardiovasc Med       Date:  2017-05

5.  Carbohydrate antigens as potential biomarkers for the malignancy in patients with idiopathic deep venous thrombosis: a retrospective cohort study.

Authors:  Miao Yu; Yun-Hong Wang; Ahmed M E Abdalla; Wen-Qi Liu; Fei Mei; Jian Wang; Chen-Xi Ouyang; Yi-Qing Li
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-10-16

6.  Combined pulmonary venous thromboembolism and renal artery thrombosis in a patient with non-small cell lung cancer.

Authors:  Gaurang Mavani; Stephen Machnicki; Ronit Lavie
Journal:  Clin Kidney J       Date:  2014-07-09

7.  Postoperative 30-day mortality following surgical resection for colorectal cancer in veterans: changes in the right direction.

Authors:  Jessica A Davila; Linda Rabeneck; David H Berger; Hashem B El-Serag
Journal:  Dig Dis Sci       Date:  2005-09       Impact factor: 3.199

8.  Phase II, parallel-design study of preoperative combined modality therapy and the matrix metalloprotease (mmp) inhibitor prinomastat in patients with esophageal adenocarcinoma.

Authors:  Elisabeth I Heath; Barbara A Burtness; Lawrence Kleinberg; Ronald R Salem; Stephen C Yang; Richard F Heitmiller; Marcia I Canto; Jonathan P S Knisely; Mark Topazian; Elizabeth Montgomery; Nancy Tsottles; Yazdi Pithavala; Bridget Rohmiller; Mary Collier; Arlene A Forastiere
Journal:  Invest New Drugs       Date:  2006-03       Impact factor: 3.850

9.  [Adenocarcinoma-associated nonbacterial thrombotic endocarditis as the cause of recurrent strokes].

Authors:  J Katchanov; F Doepp; A C Borges; G Bohner; R Klingebiel; S Ziemer; F Masuhr; R Zschenderlein
Journal:  Nervenarzt       Date:  2005-04       Impact factor: 1.214

10.  Rat prostate tumors express cancer procoagulant, an activator of coagulation factor X.

Authors:  Malgorzata Kamocka; Morris Pollard; Mark Suckow; Wojciech P Mielicki; Elliot D Rosen
Journal:  Comp Med       Date:  2008-06       Impact factor: 0.982
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.